PHARMACEUTICAL INDUSTRY SYMPOSIUM 9 BY SANDOZ

RIXATHON® development and real world  evidence data - by Sandoz

Experiences from real clinical practice in Serbia – efficacy and safety of Sandoz rituximab biosimilar Doc. D-r Darko Antić, UKC Serbia Belgrade
Clinical development and main clinical data supporting the use of RIXATHON® Dr Martin Ivanovski, UC of hematology Skopje